If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquila Euro. Regulatory News (AERS)

Share Price Information for Aquila Euro. (AERS)

Share Price is delayed by 15 minutes
Get Live Data
15.35    0.00 (0.00%)
Bid:
13.90
Ask:
16.80
Spread: 2.90 (20.863%)
Market Cap: £58.04m
AERS Live PriceLast checked at - London Stock Exchange

Intraday Aquila Euro. Share Chart

Initiation from QuotedData

15 Jun 2023 13:54

RNS Number : 8850C
Aquila European Renewables PLC
15 June 2023
 

 

Aquila European Renewables - Initiation from QuotedData

15th June 2023

Sunny days are here again

Aquila European Renewables (AERI) is about four years old. Since launch, it has built up a 464MW portfolio of operational solar, wind and hydropower projects, spread across six European power markets. It has also generated returns in line with the target that it set at launch, returning an average of 7.2% per year against a target of 6.0-7.5%.

For 2023, AERI is targeting a dividend of 5.51 cents per share (that is euro cents - given that it invests in Europe, it presents its figures in euros), 5% ahead of the target it had for 2022. Importantly, the board reckons that this will be covered 1.8x.

Like all other renewable energy funds currently, AERI's shares trade on a discount to net asset value (NAV). However, its board has been proactive in addressing this through share buybacks. On 14 June, shareholders voted in favour of the continuation of the company at this year's annual general meeting (AGM). Commendably, mindful of the share price discount to NAV, the board has brought forward the next vote scheduled for 2027 - to 2024.

With an established cash-generative portfolio, the prospect of adding further cover to the dividend, a healthy pipeline of new projects, and calmer conditions returning to markets, AERI's future looks bright.

Full Research:

https://quoteddata.com/research/aquila-european-renewables-sunny-days-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Aquila European Renewables Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABDGDLGUBDGXU
Date   Source Headline
15th Oct 20203:26 pmRNSHolding(s) in Company
14th Oct 20205:20 pmRNSHolding(s) in Company
14th Oct 20205:09 pmRNSHolding(s) in Company
13th Oct 20205:21 pmRNSHolding(s) in Company
13th Oct 202012:50 pmRNSHolding(s) in Company
9th Oct 20207:00 amRNSIssue of Equity
6th Oct 202011:40 amRNSResult of General Meeting
30th Sep 20202:58 pmRNSDividend Declaration
17th Sep 202010:01 amRNSPublication of a Prospectus and Circular
15th Sep 20207:00 amRNSHalf-year Report
11th Sep 20208:51 amRNSAcquisition
2nd Sep 20203:04 pmRNSTotal Voting Rights
5th Aug 20203:50 pmRNSIssue of Equity to Investment Adviser
5th Aug 20207:02 amRNSIssue of Equity to Investment Adviser
5th Aug 20207:01 amRNSDividend Declaration
5th Aug 20207:00 amRNSNet Asset Value and Factsheet - 30 June 2020
31st Jul 20207:00 amRNSChange of Registered Office
8th Jun 20204:48 pmRNSResult of AGM
5th Jun 20204:19 pmRNSInvestment Update
13th May 20207:00 amRNSIssue of Equity to Investment Adviser
12th May 20207:02 amRNSNet Asset Value and Factsheet - 31 March 2020
12th May 20207:00 amRNSDividend Declaration
28th Apr 20207:00 amRNSFinal Results
2nd Apr 20202:59 pmRNSHolding(s) in Company
1st Apr 20206:18 pmRNSTotal Voting Rights
23rd Mar 20207:00 amRNSInvestment Update
11th Mar 20206:07 pmRNSHolding(s) in Company
11th Mar 20205:54 pmRNSHolding(s) in Company
9th Mar 20201:35 pmRNSHolding(s) in Company
6th Mar 20202:03 pmRNSIssue of Equity
5th Mar 20207:00 amRNSProposed Issue of Equity
11th Feb 202012:37 pmRNSIssue of Equity to Investment Adviser
11th Feb 202012:31 pmRNSNet Asset Value & Factsheet - 31 December 2019
11th Feb 202012:24 pmRNSDividend Declaration
22nd Jan 20204:46 pmRNSHolding(s) in Company
22nd Jan 20209:43 amRNSHolding(s) in Company
20th Jan 20203:08 pmRNSHolding(s) in Company
20th Dec 20194:50 pmRNSInvestment Update
12th Dec 20197:00 amRNSInvestment Update
6th Dec 20193:02 pmRNSHolding(s) in Company
2nd Dec 20195:24 pmRNSTotal Voting Rights
29th Nov 201912:46 pmRNSHolding(s) in Company
6th Nov 20197:10 amRNSIssue of Equity to Investment Adviser
6th Nov 20197:05 amRNSDividend Declaration
6th Nov 20197:00 amRNSNet Asset Value and Factsheet - 30 September 2019
11th Oct 201911:46 amRNSLSE - Green Economy Classification and Mark
8th Oct 20199:39 amRNSAppointment of Corporate Broker
27th Sep 20194:30 pmRNSInvestment Update
5th Aug 20193:52 pmRNSInvestment Update
31st Jul 20199:50 amRNSReduction of the Share Premium Account

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.